Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system

Detalles Bibliográficos
Autores principales: Guo, Haoning, Wang, Bin, Yuan, Shuying, Wu, Silin, Liu, Jing, He, Miaoquan, Wang, Jisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683689/
https://www.ncbi.nlm.nih.gov/pubmed/36438806
http://dx.doi.org/10.3389/fphar.2022.1075966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683689/
https://www.ncbi.nlm.nih.gov/pubmed/36438806
http://dx.doi.org/10.3389/fphar.2022.1075966

Ejemplares similares